IDXX

Today, 10:33 AMIDEXX raises 2026 revenue and EPS guidance after Q3 beat with 10% organic growth despite softer U.S. vet visits

Peers: ZTS DHR DGX LH A TMO WAT ELAN NEOG BIO

| Held by: VTI VOO QQQ VO IVV SPY VUG VOT XLV RSP

Scroll to Statements

Index	NDX, S&P 500
Market Cap	52.54B
Enterprise Value	53.43B
Income	1.14B
Sales	4.55B
Book/sh	20.44
Cash/sh	2.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	11000
IPO	Jun 21, 1991

P/E	46.87
Forward P/E	39.84
PEG	2.99
P/S	11.54
P/B	32.62
P/C	266.77
P/FCF	42.01
EV/EBITDA	33.05
EV/Sales	11.74
Quick Ratio	0.81
Current Ratio	1.11
Debt/Eq	0.68
LT Debt/Eq	0.25
Option/Short	Yes / Yes

EPS (ttm)	14.23
EPS next Y	16.74
EPS next Q	3.40
EPS this Y	12.80%
EPS next Y	13.44%
EPS next 5Y	13.32%
EPS past 3/5Y	17.66% 14.28%
Sales past 3/5Y	8.52% 9.72%
EPS Y/Y TTM	18.22%
Sales Y/Y TTM	12.77%
EPS Q/Q	17.55%
Sales Q/Q	9.66%
Earnings	Nov 02 BMO
EPS/Sales Surpr.	7.63% 1.89%

Insider Own	0.38%
Insider Trans	-0.73%
Inst Own	97.49%
Inst Trans	0.21%
ROA	33.65%
ROE	74.21%
ROIC	56.62%
Gross Margin	62.53%
Oper. Margin	32.12%
Profit Margin	25.03%
SMA20	21.06%
SMA50	24.30%
SMA200	16.50%
Trades

Shs Outstand	78.87M
Shs Float	78.48M
Short Float	2.46%
Short Ratio	3.48
Short Interest	1.93M
52W High	769.98 -13.39%
52W Low	500.61 33.21%
Volatility	3.22% 2.47%
ATR (14)	22.54
RSI (14)	76.23
Beta	1.55
Rel Volume	3.09
Avg Volume	554.25K
Volume	1,472,958

Perf Week	16.95%
Perf Month	28.64%
Perf Quarter	13.39%
Perf Half Y	18.42%
Perf YTD	-1.43%
Perf Year	5.93%
Perf 3Y	58.99%
Perf 5Y	6.30%
Perf 10Y	532.44%
Recom	1.89
Target Price	721.92
Prev Close	551.21
Price	666.85
Change %	20.98%

Consensus

Buy

Avg. Price Target

$721.92

Implied Upside

+8.3%

Analysts15incl. previous ratings

Rating Distribution9 Buy · 6 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Oct 16, 2026	Initiated	GGoldman	Buy	$740	+11.0%
Oct 12, 2026	Initiated	KKeyBanc Capital Markets	Sector Weight
Apr 15, 2026	Initiated	CCitigroup	Neutral	$650	-2.5%
Dec 09, 2025	Initiated	BBarclays	Overweight	$850	+27.5%
Oct 31, 2025	Upgrade	SStifel	Hold → Buy	$700	+5.0%
Oct 01, 2025	Initiated	UUBS	Neutral	$720	+8.0%
Aug 05, 2025	Reiterated	BBTIG Research	Buy	$545 → $785	+17.7%
Jul 01, 2025	Initiated	JJefferies	Buy	$625	-6.3%
Dec 02, 2024	Initiated	LLeerink Partners	Outperform	$500	-25.0%
Jul 25, 2024	Initiated	BBTIG Research	Buy	$580	-13.0%
Jan 30, 2024	Downgrade	PPiper Sandler	Overweight → Neutral	$525	-21.3%
Dec 07, 2023	Initiated	EExane BNP Paribas	Outperform	$602	-9.7%
Dec 04, 2023	Upgrade	CCleveland Research	Neutral → Buy
Aug 02, 2023	Downgrade	AAtlantic Equities	Overweight → Neutral	$610	-8.5%
Jul 25, 2022	Downgrade	SStifel	Buy → Hold	$415	-37.8%
Jul 21, 2022	Upgrade	GGoldman	Neutral → Buy	$530 → $435	-34.8%
Jul 12, 2022	Initiated	PPiper Sandler	Overweight	$440	-34.0%
May 05, 2022	Downgrade	BBofA Securities	Buy → Neutral	$550 → $470	-29.5%
Feb 08, 2022	Initiated	AAtlantic Equities	Overweight	$650	-2.5%
Nov 18, 2021	Initiated	MMorgan Stanley	Overweight

Today 11:47AM	Idexx Is Today's Best S&P 500 Stock. It's Defying an Industry Slump. (Barrons.com) +20.98%
11:01AM	IDEXX Raises Its Growth Outlook A Third Time As Diagnostics Volumes Outrun Falling Vet Visits, While CoVet Trims The Margin Guide (Earnings Whispers)
08:18AM	IDEXX Laboratories Shares Rise 2.57% as Q3 Earnings Beat Forecasts and FY2026 Guidance Increases (InvestorsHub)
07:15AM	IDEXX Labs beats estimates, raises guidance as stock gains (Investing.com)
06:42AM	Idexx: Q3 Earnings Snapshot (Associated Press)
05:30AM	Loading…
05:30AM	IDEXX Laboratories Announces Third Quarter Results (Business Wire)
Oct-26-26 11:43AM	IDEXX Must Show New Cancer Tests Can Outrun Soft Vet Visits In Q3 (Earnings Whispers)
Oct-20-26 09:06AM	Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX (Investing.com)
Oct-12-26 09:41AM	Salesforce upgraded, Adobe downgraded: Wall Street's top analyst calls (The Fly)
Oct-01-26 11:30AM	IDEXX Laboratories to Release 2026 Third Quarter Financial Results (Business Wire)
Sep-30-26 09:00AM	Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories (PR Newswire)
Sep-17-26 03:00AM	IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection (Business Wire)
Sep-16-26 07:00AM	IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence (Business Wire)
Sep-10-26 01:05PM	Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? (Trefis)
Aug-31-26 02:00PM	IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference (Business Wire)
07:00AM	Loading…
Aug-11-26 07:00AM	IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test (Business Wire)
Aug-04-26 05:04PM	IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
08:15AM	IDEXX Laboratories Shares Climb After Earnings Beat and Improved Full-Year Outlook (InvestorsHub)
06:36AM	Idexx: Q2 Earnings Snapshot (Associated Press)
06:30AM	IDEXX Laboratories Announces Second Quarter Results (Business Wire)
Jul-28-26 10:06AM	IDEXX Releases 2025 Corporate Responsibility Report Highlighting Innovation and Sustainability Progress (InvestorsHub)
07:00AM	IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals (Business Wire)
Jul-01-26 04:00PM	IDEXX Laboratories to Release 2026 Second Quarter Financial Results (Business Wire)
May-26-26 07:00AM	IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection (Business Wire)
May-18-26 08:34AM	The Biology Came First. (Business Wire)
May-14-26 04:34PM	IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day (Business Wire)
May-05-26 06:35AM	Idexx: Q1 Earnings Snapshot (Associated Press)
06:30AM	IDEXX Laboratories Announces First Quarter Results (Business Wire)
Apr-15-26 09:47AM	Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
Apr-13-26 08:03PM	IDEXX Laboratories Stock Up 39.4% in a Year: What's Driving It? (Quartz)
01:00PM	Loading…
Apr-08-26 01:00PM	IDEXX Laboratories to Release 2026 First Quarter Financial Results (Business Wire)
Apr-01-26 03:00AM	IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma (Business Wire)
Mar-23-26 01:38PM	Pet Services Jump 5.1% as Vet Visits Fall for 16th Straight Quarter (GuruFocus.com)
Mar-16-26 04:19AM	Is IDEXX Laboratories Stock Outperforming the S&P 500? (Barchart)
Mar-11-26 05:50AM	Top Hedge Fund Manager Sounds the Alarm on Market Risk. Here Are 4 Ways to Play a Possible Selloff (TipRanks)
Mar-10-26 09:45AM	Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock (Zacks)
Mar-09-26 01:03PM	IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It? (Zacks)
11:40AM	SONVY vs. IDXX: Which Stock Should Value Investors Buy Now? (Zacks)
Mar-06-26 09:38AM	Is This the Right Time to Retain IDXX Stock in Your Portfolio? (Zacks)
Mar-05-26 07:26PM	Analyst Report: IDEXX Laboratories, Inc. (Morningstar Research)
Mar-04-26 11:30AM	Why Is Idexx (IDXX) Up 0.5% Since Last Earnings Report? (Zacks)
Feb-28-26 01:07AM	IDEXX Laboratories Touts Exceptional Q4, Targets 8%-10% 2026 Growth at BofA Summit (MarketBeat)
Feb-26-26 05:35AM	TheStreet Pro: Four Stocks that Will Win Despite Irrational Panic over AI (TipRanks)
Feb-25-26 10:25AM	How Is Thermo Fisher Scientifics Stock Performance Compared to Other Medical Devices Stocks? (Barchart)
Feb-24-26 07:14PM	Analyst Report: IDEXX Laboratories, Inc. (Morningstar Research)
Feb-23-26 03:48PM	Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX) (Insider Monkey)
10:56AM	Here's What Analysts Are Saying About IDEXX Laboratories (IDXX) (Insider Monkey)
Feb-20-26 11:40AM	SONVY or IDXX: Which Is the Better Value Stock Right Now? (Zacks)
09:14AM	Here's Why IDEXX Laboratories (IDXX) Shares are Re-Rating to Historical Average (Insider Monkey)
07:56AM	Are Wall Street Analysts Bullish on IDEXX Laboratories Stock? (Barchart)
Feb-15-26 06:53AM	IDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets (Insider Monkey)
Feb-13-26 09:04PM	Analyst Report: IDEXX Laboratories, Inc. (Morningstar Research)
Feb-12-26 04:15PM	IDEXX Laboratories to Present at Two Institutional Investor Conferences (Business Wire)
Feb-11-26 08:45AM	Baron Partners Fund is Leveraging IDEXX Laboratories' (IDXX) Long-Term Growth Drivers (Insider Monkey)
Feb-10-26 09:45AM	Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock (Zacks)
Feb-07-26 11:12AM	IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory (Insider Monkey)
Feb-05-26 09:22AM	IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market (Insider Monkey)
08:56AM	Fidelity Growth Strategies Fund Avoids IDEXX Laboratories (IDXX) Due to Questionable Growth Durability (Insider Monkey)
Feb-04-26 11:55AM	Reasons to Hold Veeva Systems Stock in Your Portfolio for Now (Zacks)
11:40AM	IQV or IDXX: Which Is the Better Value Stock Right Now? (Zacks)
Feb-03-26 10:29AM	Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test (Zacks)
Feb-02-26 04:26PM	Stock Market Today: Dow Jumps As Trump Touts This Deal; Robinhood Plunges But Palantir Pops (Live Coverage) (Investor's Business Daily)
04:25PM	Idexx Tumbles Following An 'Impressive' Report; Can It Shake Pet-Health Challenges? (Investor's Business Daily)
04:06PM	Analyst Report: IDEXX Laboratories, Inc. (Morningstar Research)
04:00PM	IDEXX Laboratories Inc (IDXX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
01:40PM	Russell 2000 Rallies, Gold And Silver Extend Losses: What's Moving Markets Monday? (Benzinga)
01:05PM	Why Is IDEXX Labs Stock Falling Today? (Benzinga)
12:52PM	IDEXX Laboratories Q4 Earnings Call Highlights (MarketBeat)
11:19AM	Stocks Gain on US Manufacturing Strength (Barchart)
10:14AM	Stock Indexes Climb as Chip Makers and AI Infrastructure Stocks Rebound (Barchart)
09:51AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
09:42AM	IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
09:30AM	Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:52AM	Idexx Laboratories Stock Topples Despite Its 'Impressive' Report (Investor's Business Daily)
07:40AM	Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates (Zacks)
06:48AM	Idexx: Q4 Earnings Snapshot (Associated Press Finance)
06:48AM	IDEXX Laboratories Guides FY26 In Line With Estimates - Update (RTT News)
06:30AM	IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 09:36AM	IDEXX Laboratories, Inc. (IDXX): Innovation and Seamless Leadership Transition Drive 2026 Outlook (Insider Monkey)
Jan-30-26 12:07PM	SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval (Zacks)
Jan-29-26 12:47PM	Reasons to Add AngioDynamics Stock to Your Portfolio for Now (Zacks)
12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX) (Zacks)
Jan-28-26 12:35PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
12:31PM	OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System (Zacks)
09:15AM	Curious about Idexx (IDXX) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
07:43AM	Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings (Zacks)
Jan-27-26 11:47AM	BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry (Zacks)
Jan-23-26 11:43AM	ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
Jan-22-26 12:32PM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
Jan-21-26 10:49AM	CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February (Zacks)
07:58AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:54AM	Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? (Zacks)
Jan-19-26 04:27PM	Top Research Reports for GE Aerospace, KLA & Parker-Hannifin (Zacks)
12:34PM	SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal (Zacks)
12:31PM	Here's Why You Should Hold DaVita Stock in Your Portfolio for Now (Zacks)
Jan-15-26 10:53AM	Masimo Stock Declines Despite Solid Preliminary Q4 Revenues (Zacks)
10:37AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
08:24AM	BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kingsley Lawrence D	Director	Sep 04 '26	Option Exercise	114.17	2,203	251,517	11,771	Sep 09 05:00 PM
Kingsley Lawrence D	Director	Sep 04 '26	Sale	532.08	2,203	1,172,178	9,568	Sep 09 05:00 PM
LAWRENCE D KINGSLEY	Director	Sep 04 '26	Proposed Sale	532.08	2,203	1,172,178		Sep 04 04:03 PM
Emerson Andrew	EVP, CFO and Treasurer	Aug 20 '26	Option Exercise	178.26	265	47,239	4,507	Aug 24 05:00 PM
FENNELL GEORGE	Executive Vice President	Jun 01 '26	Option Exercise	0.00	639	0	10,717	Jun 02 05:00 PM
Margaret Anne Szostak	Director	May 20 '26	Proposed Sale	553.58	1,344	744,012		May 20 06:30 PM
Vandebroek Sophie V.	Director	May 07 '26	Option Exercise	0.00	257	0	905	May 11 05:11 PM
SZOSTAK M ANNE	Director	May 07 '26	Option Exercise	0.00	257	0	519	May 11 05:10 PM
Peacock Karen	Director	May 07 '26	Option Exercise	0.00	101	0	102	May 11 05:10 PM
Kingsley Lawrence D	Director	May 07 '26	Option Exercise	0.00	339	0	9,568	May 11 05:10 PM
JUNIUS DANIEL M	Director	May 07 '26	Option Exercise	0.00	257	0	3,561	May 11 05:10 PM
HOOLEY JOSEPH L	Director	May 07 '26	Option Exercise	0.00	158	0	276	May 11 05:10 PM
Underberg Sharon E.	EVP, GC & Corporate Secretary	Mar 03 '26	Option Exercise	505.53	197	99,589	7,138	Mar 05 05:01 PM
Hunt Nimrata	Executive Vice President	Mar 03 '26	Sale	634.57	1,758	1,115,577	18,141	Mar 05 05:01 PM
NIMRATA K HUNT	Officer	Mar 03 '26	Proposed Sale	634.57	1,758	1,115,577		Mar 03 04:08 PM
MAZELSKY JONATHAN JAY	President and CEO	Feb 26 '26	Option Exercise	141.60	23,326	3,302,962	106,932	Mar 02 05:00 PM
MAZELSKY JONATHAN JAY	President and CEO	Feb 27 '26	Option Exercise	505.53	197	99,589	83,803	Mar 02 05:00 PM
MAZELSKY JONATHAN JAY	President and CEO	Feb 26 '26	Sale	657.55	23,326	15,338,081	83,606	Mar 02 05:00 PM
Hunt Nimrata	Executive Vice President	Feb 26 '26	Sale	661.54	2,693	1,781,531	19,899	Feb 27 05:03 PM
JONATHAN J MAZELSKY	Officer	Feb 26 '26	Proposed Sale	657.55	23,326	15,338,081		Feb 26 04:37 PM
NIMRATA K HUNT	Officer	Feb 25 '26	Proposed Sale	661.54	2,693	1,781,531		Feb 25 05:48 PM
Erickson Michael G	Executive Vice President	Feb 17 '26	Option Exercise	170.13	5,371	913,772	18,064	Feb 19 06:00 PM
Erickson Michael G	Executive Vice President	Feb 19 '26	Option Exercise	227.83	2,399	546,557	15,092	Feb 19 06:00 PM
Erickson Michael G	Executive Vice President	Feb 17 '26	Sale	627.38	5,371	3,369,666	12,693	Feb 19 06:00 PM
Vandebroek Sophie V.	Director	Feb 17 '26	Option Exercise	333.90	945	315,536	2,112	Feb 19 06:00 PM
Vandebroek Sophie V.	Director	Feb 17 '26	Sale	628.62	1,464	920,293	648	Feb 19 06:00 PM
Underberg Sharon E.	EVP, GC & Corporate Secretary	Feb 14 '26	Option Exercise	0.00	832	0	7,192	Feb 17 07:31 PM
Smith Martin Alexander	Executive Vice President	Feb 14 '26	Option Exercise	0.00	1,004	0	2,459	Feb 17 07:31 PM
Schreck Michael	Executive Vice President	Feb 14 '26	Option Exercise	0.00	1,959	0	3,965	Feb 17 07:31 PM
MAZELSKY JONATHAN JAY	President and CEO	Feb 14 '26	Option Exercise	0.00	2,057	0	84,521	Feb 17 07:30 PM
Lane Michael	Executive Vice President	Feb 14 '26	Option Exercise	0.00	1,092	0	8,245	Feb 17 07:30 PM
Johnson Michael Perkins	Executive Vice President	Feb 14 '26	Option Exercise	0.00	573	0	2,973	Feb 17 07:30 PM
Hunt Nimrata	Executive Vice President	Feb 14 '26	Option Exercise	0.00	2,587	0	23,746	Feb 17 07:30 PM
FENNELL GEORGE	Executive Vice President	Feb 14 '26	Option Exercise	0.00	454	0	10,277	Feb 17 07:30 PM
Erickson Michael G	Executive Vice President	Feb 14 '26	Option Exercise	0.00	2,363	0	13,667	Feb 17 07:30 PM
Emerson Andrew	EVP, CFO and Treasurer	Feb 14 '26	Option Exercise	0.00	456	0	4,345	Feb 17 07:30 PM
SOPHIE V VANDEBROEK	Director	Feb 17 '26	Proposed Sale	628.62	1,464	920,293		Feb 17 04:25 PM
MICHAEL G ERICKSON	Officer	Feb 17 '26	Proposed Sale	627.38	5,371	3,369,667		Feb 17 04:23 PM
FENNELL GEORGE	Executive Vice President	Feb 10 '26	Option Exercise	67.85	11,345	769,758	21,168	Feb 11 05:01 PM
FENNELL GEORGE	Executive Vice President	Feb 09 '26	Option Exercise	67.85	1,476	100,147	9,823	Feb 11 05:01 PM
FENNELL GEORGE	Executive Vice President	Feb 10 '26	Sale	646.72	11,345	7,336,993	9,823	Feb 11 05:01 PM
GEORGE FENNELL	Officer	Feb 10 '26	Proposed Sale	646.72	11,345	7,336,994		Feb 10 04:05 PM
Hunt Nimrata	Executive Vice President	Nov 07 '25	Option Exercise	382.28	12,530	4,789,947	30,574	Nov 10 05:01 PM
Hunt Nimrata	Executive Vice President	Nov 07 '25	Sale	703.34	9,425	6,629,014	21,149	Nov 10 05:01 PM
NIMRATA K HUNT	Officer	Nov 07 '25	Proposed Sale	703.35	9,425	6,629,060		Nov 07 04:07 PM

IDEXX Laboratories, Inc. engages in the development, manufacturing, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing industries. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.

Executive ChairmanMr. Jonathan J. Mazelsky

Executive VPMr. Andrew Emerson

Executive VP and GM Global Reference LaboratoriesMr. Michael J. Lane

Executive Vice President of Global Operations and R&DDr. Martin Smith Ph.D.

CEOMr. Michael G. Erickson Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Idexx Laboratories Inc

Upgrade your Finviz experience